Available Technologies

No technologies match these criteria.
Schedule UC TechAlerts to receive an email when technologies are published that match this search. Click on the Save Search link above

Find technologies available for licensing from UCSF.

Chemical Modulators of Nurr1

Long thought to be undruggable, Nurr1 is a nuclear receptor and transcription factor involved in the development, maintenance, and survival of midbrain dopaminergic neurons, which makes it an attractive target for developing therapeutics for such indications of Parkinson’s disease, multiple sclerosis, and schitzophrenia.

Brain-Specific Kinase Inhibition to Mitigate Systemic Toxicity

The goal of this invention is to overcome the challenges of previous approaches by selectively targeting treatments to the CNS without peripheral toxicity. Kinase inhibition is targeted to the central nervous system (CNS) by combining brain-permeable kinase inhibitors and a brain-impermeable blocking molecule.

Chimeric Kinase Inhibitors with Increased Activity

This invention describes newly generated kinase inhibitors that demonstrate enhanced and attenuated action over their parent kinase inhibitors. These molecules can be used alone but, when combined with novel blocking molecules, the action of these chimeric kinases can be targeted for action in the central nervous system (CNS).

cBCI: Method and System for Diagnosing and Training Cognitive Fitness and Targeted Neural Network Function Underlying Cognitive Fitness in an Integrated Digital Approach

The inventors have created a brain computer interface (BCI) that serves as a diagnostic and training tool of cognitive abilities and neural network function.

Simultaneous Acquisition Of Multiple Epi-Fluorescense Micrographs

UCSF researchers have developed a novel microscope system which allows multiple images of a single sample to be acquired simultaneously.  These images are structured and, when coupled with conventional structured illumination image processing methods, can provide video rate, super-resolution micrographs. 

NOVEL ANTIBODIES AGAINST EPHA2 FOR RESEARCH, DIAGNOSIS, AND TREATMENT OF CANCER

A novel monoclonal human antibody specific to the cell-surface exposed protein EphA2, which is over-expressed in many forms of cancer and is a validated therapeutic target.

Novel Small Molecules to Prevent Neurodegenerative Diseases

UCSF scientists have developed a novel biophysical-biochemical screening platform to identify small molecules that prevent the oligomerization of alpha-synuclein: the rate-limiting step in the formation of toxic fibrils in the pathologies of Parkinson’s disease, Lewy Body Dementia, and other neurodegenerative diseases. With this technology, novel families of small molecules have been found with the capacity to reverse multiple pathogenic markers of disease progression in cells.

Graphene Oxide Based Affinity Grids As Sample Supports For High- Resolution Cryo Electron Microscopy.

Inventors at UCSF have developed a novel and economical method to produce a new generation of Cryo-EM sample grids that bind purify and protect biomolecule samples.